Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1884 of 6351
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects, and best dose of entinostat and ZEN003694 in treating patients with solid tumors that have spread to other places in the body (advanced) or does not respond to treatment (refractory). Entinostat is in a class of drugs called h…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could skipping the breathing tube ease recovery after throat surgery?
Symptom relief CompletedTransnasal humidified rapid-insufflation ventilatory exchange(THRIVE), or also termed high flow nasal oxygenation (HFNO) is a method of supplying heated, humidified high concentrations of oxygen via nasal cavity. This study hypothesizes that in general anesthesia for laryngeal mi…
Sponsor: Ajou University School of Medicine • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New hope for advanced cancer? experimental drug ZGGS18 enters human trials
Disease control Recruiting nowA clinical study to assess dose escalation, tolerance, safety, pharmacokinetics, and multi cohort expansion of ZGGS18 in patients with advanced solid tumors
Phase 1/2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Brain zaps boost walking and thinking in Parkinson's patients
Symptom relief CompletedThis study aimed to evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) applied to the left dorsolateral prefrontal cortex on cognitive function and dual-task performance in individuals with Parkinson's disease. Participants completed ten rTMS sessions ove…
Sponsor: University of Gaziantep • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New drug could ease teen IBS constipation pain
Symptom relief OngoingThis is a randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of tenapanor (25 mg and 50 mg) in pediatric patients (≥12 and \<18 years old) with IBS-C when administered twice daily (BID) for 12 consecutive weeks.
Phase 3 • Sponsor: Ardelyx • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New combo therapy targets hard-to-treat lung cancer in chinese patients
Disease control OngoingThis is an open-label, interventional, multiple-center, exploratory Phase II study sponsored by AstraZeneca Investment(China)Co., LTD. to evaluate the efficacy and safety of Savolitinib combine with Durvalumab in Chinese EGFR wild-type locally advanced or metastatic NSCLC patient…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New sensor could save replanted limbs by spotting trouble early
Knowledge-focused OngoingInvestigators will test if changes in CO2 is detected postoperatively in ischemic tissue in a replanted extremity of a traumatically amputated upper or lower extremity. IscAlert is measuring continuously CO2 in muscular and subcutaneous tissue. IscAlert is inserted distal to the …
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Can a blood clot or gum graft erase black triangles between teeth?
Disease control CompletedObjective: Titanium-prepared platelet-rich fibrin (T-PRF) has emerged as a promising biomaterial in periodontal regenerative procedures. The aim of this study will be to compare the clinical effectiveness of de-epithelialized gingival grafts (DGG) and T-PRF in the reconstruction …
Sponsor: Pamukkale University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Rewiring the brain to fight back pain?
Symptom relief CompletedIn this study, the effect of sensory discrimination training on cortical reorganization, pain and functionality in chronic nonspecific low back pain in which central sensitization is dominant will be investigated.
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Can online peer support help women with HIV and trauma stay on track?
Disease control Recruiting nowA two-arm RCT will be conducted to test the efficacy of Women SHINE, a web-based trauma-informed peer navigation-social support intervention (Figure 2). A total of 360 women living with HIV/AIDS (WLHA) with a history of adulthood interpersonal violence who have been prescribed AR…
Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Mind-Controlled hand therapy shows promise for spinal cord injury recovery
Disease control CompletedThe goal of this clinical trial is to validate the efficacy of a Brain-Computer Interface (BCI)-based intervention for hand motor recovery in subacute cervical spinal cord injured (SCI) patients during rehabilitation. The study will provide evidence for the clinical/neurophysiolo…
Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Disease control
Last updated Jun 26, 2026 16:58 UTC
-
New immunotherapy DF9001 targets Hard-to-Treat cancers
Disease control CompletedDF9001-001 is a study of a new molecule that targets natural killer (NK) cells and T-cell activation signals to specific receptors on cancer cells. The study will occur in two phases. The first phase will be a dose escalation phase, enrolling patients with various types of solid …
Phase 1/2 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Brain pressure monitor could boost recovery after major bleed
Disease control CompletedSpontaneous cerebral hemorrhage (SICH) is a hemorrhage caused by the rupture of a blood vessel within the brain parenchyma that is non-traumatic. Its rapid onset and dangerous condition seriously threaten human health; it accounts for about 15% of strokes and 50% of stroke-relate…
Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 26, 2026 15:06 UTC
-
Steroid shot before angioplasty may limit heart damage
Disease control CompletedThe overall primary objective of the PULSE-MI trial is to test the hypothesis that administration of single-dose glucocorticoid pulse therapy in the pre-hospital setting reduces final infarct size in patients with ST-segment elevation myocardial infarction (STEMI) treated with pr…
Phase 2 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo pill aims to halt liver scarring in NASH patients
Disease control CompletedA study to investigate the use of combination therapy with two investigational products for the treatment of adult patients with Nonalcoholic steatohepatitis (NASH).
Phase 2 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can tailored rehab after ACL surgery keep athletes safer?
Prevention Recruiting nowFollowing reconstruction of the anterior cruciate ligament (ACL), a standardized rehabilitation protocol is carried out by a physiotherapist. In France, a well-established rehabilitation consensus guides the first phase of 3 months postoperatively and patient compliance is genera…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with rare lung condition: macitentan shows promise in small study
Disease control CompletedThe purpose of this study is to evaluate the effect of macitentan on hemodynamic measures at Week 24 in pediatric populations.
Phase 3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy may stop stroke from getting worse
Disease control CompletedPerforating artery territorial infarction (PAI) refers to a single ischemic lesion in a single perforating arterial territory and branch atheromatous disease (BAD) is an important type. BAD related stroke accounts for 10%-15% ischemic cerebral infarction and is closely related to…
Phase 4 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Experimental pill takes on deadliest brain tumor
Disease control OngoingThis is a phase 1 investigational study to assess the safety and preliminary efficacy of oral gallium maltolate (GaM) in participants with relapsed glioblastoma (GBM).
Phase 1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Tailored therapy for medulloblastoma shows promise but trial cut short
Disease control Stopped earlyMedulloblastoma is a rare brain malignancy, mainly affecting children. Treatment of this rapidly growing tumor begins with maximal surgical removal plus radiation and chemotherapy. Treatment toxicity is high. Post-pubertal and pediatric medulloblastomas are biologically and progn…
Phase 2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC